| 1. | Eirini Theodoraki | 2023 | Long term safety and risk factors of adverse events of biologics in patients with inflammatory bowel disease |
| 2. | Eleni Orfanoudaki | 2022 | Optimizing biologic therapy in patients with Inflammatory Bowel Diseases |
| 3. | Maria Fragaki | 2020 | Study of the frequency, natural history and therapeutics of liver cirrhosis |
| 4. | Eleni Kontaki | 2018 | Regulation of immune response in Inflammatory Bowel Disease and experimental colitis models |
| 5. | Constantina Coucoutsi | 2018 | Study of the genetics of inflammatory bowel disease |
| 6. | George Emmanouil | 2018 | The role of angiogenic and angiostatic C-X-C chemiokines in the development of colon cancer |
| 7. | Evangelos Voudoukis | 2016 | The role of platelets in inflammatory bowel disease |
| 8. | Sotiris Terzoudis | 2016 | Epidemiology, risk factors and pathogenetic mechanisms of osteoporosis and fractures in Greek cretan IBD patients |
| 9. | Aikaterini Mantaka | 2016 | Inheritance and primary biliary cirrhosis |
| 10. | Ioannis Drositis | 2015 | Epidemiological and molecular analysis of hepatitis viruses in a well-defined rural area of Crete |
| 11. | Georgios Ayiomamitis | 2015 | Study of telomerase and cycloxygenase-II on colon and rectal cancers |
| 12. | Stefanos Klironomos | 2014 | Effects of somatostatin on hepatic stellate cells |
| 13. | Ioannis Drygiannakis | 2012 | The role of myofibroblasts in the fibrotic process in Crohn's disease |
| 14. | Panteleimon Oustamanolakis | 2012 | Investigation of mechanisms of anemia with a particular emphasis on disorders of iron homeostasis and erythropoiesis in patient with inflammatory bowel diseases |
| 15. | Maria Georgiadou | 2011 | Study of TNFa receptors in kupffer cells and hepatocellular carcinoma |
| 16. | Argyro Voumvouraki | 2011 | The role of octreotide as anti-fibrotic agent in patients with chronic liver disease |
| 17. | Nikos Tsagarakis | 2010 | Study of the biological behavior of caspases in hepatocellular carcinoma cells |
| 18. | Ourania Sfakianaki | 2010 | Role of autoantibodies that recognize characterized and new antigens of the nuclear envelope in the diagnosis, prognosis and therapeutic response of patients with primary biliary cirrhosis |
| 19. | Pinelopi Manousou | 2010 | Crosstalk between epithelial cells and T lymphocytes in inflammatory bowel diseases the role of chemokine |
| 20. | Leonidas Bourikas | 2010 | The study of the effect of chemopreventive agents on apoptosis of colonic epithelial cells |
| 21. | Dimitrios Samonakis | 2010 | Study on the parametrus related to the anticancer effect of somatostatin on HCC |
| 22. | Konstantinos Karmiris | 2009 | The role of adipokines in inflammatory bowel diseases |
| 23. | Vasileios Pagkalos | 2009 | The role of fatty acids of the adipose tissue and the gastric mucosa in the defence of the gastric mucosa |
| 24. | Filippos Dimoulios | 2007 | The role of endothelin and nitric monoxide in primary biliary cirrhosis |
| 25. | Angeliki Theodoropoulou | 2006 | Mediators of inflammation and thrombosis in Inflammatory Bowel Disease (IBD) and Ischemic Colitis (IC) |
| 26. | Stavros-Dimitrios Drygiannakis | 2001 | Autoantibodies prevalence in patients with Chronic Hepatitis C (HCV) |